Related references
Note: Only part of the references are listed.Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags
Loic Dayon et al.
ANALYTICAL CHEMISTRY (2008)
Chemical and Pathway Proteomics POWERFUL TOOLS FOR ONCOLOGY DRUG DISCOVERY AND PERSONALIZED HEALTH CARE
Ulrich Kruse et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells
Ting Lei et al.
PROTEOMICS (2008)
Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis
Jung Woo Eun et al.
TOXICOLOGY (2008)
CEBS - Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data
Michael Waters et al.
NUCLEIC ACIDS RESEARCH (2008)
Quantitative mass spectrometry in proteomics: a critical review
Marcus Bantscheff et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease
Leila Choe et al.
PROTEOMICS (2007)
Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression
Angelique M. Leone et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research
Sebastian Wiese et al.
PROTEOMICS (2007)
Toxicogenomics strategies for predicting drug toxicity
Rory Martin et al.
PHARMACOGENOMICS (2006)
Predictive models of hepatotoxicity using gene expression data from primary rat hepatocytes
L. Hultin-Rosenberg et al.
XENOBIOTICA (2006)
Identification of early proteomic markers for hepatic steatosis
G. Meneses-Lorente et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
The Comparative Toxicogenomics Database: A cross-species resource for building chemical-gene interaction networks
Carolyn J. Mattingly et al.
TOXICOLOGICAL SCIENCES (2006)
Profiling the hepatic effects of flutamide in rats: A microarray comparison with classical aryl hydrocarbon receptor ligands and atypical CYP1A inducers
Kevin J. Coe et al.
DRUG METABOLISM AND DISPOSITION (2006)
Proteomic approach to study the cytotoxicity of dioscin (saponin)
Y Wang et al.
PROTEOMICS (2006)
Toxicogenomics in risk assessment: Applications and needs
DR Boverhof et al.
TOXICOLOGICAL SCIENCES (2006)
Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry
Yuzuru Shiio et al.
NATURE PROTOCOLS (2006)
Correcting common errors in identifying cancer-specific serum peptide signatures
J Villanueva et al.
JOURNAL OF PROTEOME RESEARCH (2005)
EDGE: A centralized resource for the comparison, analysis, and distribution of toxicogenomic information
KR Hayes et al.
MOLECULAR PHARMACOLOGY (2005)
A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism
S Ekins et al.
DRUG METABOLISM AND DISPOSITION (2005)
A toxicogenomic approach to drug-induced phospholipidosis:: Analysis of its induction mechanism and establishment of a novel in vitro screening system
H Sawada et al.
TOXICOLOGICAL SCIENCES (2005)
Imaging mass spectrometry: Principles and potentials
P Chaurand et al.
TOXICOLOGIC PATHOLOGY (2005)
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility
OJ Semmes et al.
CLINICAL CHEMISTRY (2005)
Progress in applying genomics in drug development
PG Lord
TOXICOLOGY LETTERS (2004)
Acute molecular markers of rodent hepatic carcinogenesis identified by transcription profiling
JA Kramer et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
EP Diamandis
MOLECULAR & CELLULAR PROTEOMICS (2004)
The ABC's (and XYZ's) of peptide sequencing
H Steen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Identification of in vitro protein biomarkers of idiosyncratic liver toxicity
J Gao et al.
TOXICOLOGY IN VITRO (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Web-based tools for mining the NCI databases for anticancer drug discovery
XL Fang et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Toxicoproteomics: Proteomics applied to toxicology and pathology
BA Wetmore et al.
TOXICOLOGIC PATHOLOGY (2004)
Prediction of torsade-causing potential of drugs by support vector machine approach
CW Yap et al.
TOXICOLOGICAL SCIENCES (2004)
A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditions
S Mian et al.
PROTEOMICS (2003)
Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue
BI Yoon et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
SELDI-TOF MS for diagnostic proteomics.
HJ Issaq et al.
ANALYTICAL CHEMISTRY (2003)
Protein analysis on a proteomic scale
E Phizicky et al.
NATURE (2003)
ProteoChip: A highly sensitive protein microarray prepared by a novel method of protein, immobilization for application of protein-protein interaction studies
Y Lee et al.
PROTEOMICS (2003)
Generation of bioreagents for protein chips
ML Phelan et al.
PROTEOMICS (2003)
Recent developments in protein microarray technology
DS Wilson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Protein arrays: The current state-of-the-art
P Cutler
PROTEOMICS (2003)
Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals:: a longitudinal population-based study
S Schneeweiss et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis
S Kennedy
BIOMARKERS (2002)
Gene expression analysis reveals chemical-specific profiles
HK Hamadeh et al.
TOXICOLOGICAL SCIENCES (2002)
Prediction of compound signature using high density gene expression profiling
HK Hamadeh et al.
TOXICOLOGICAL SCIENCES (2002)
Toxicology and genetic toxicology in the new era of toxicogenomics: impact of -omics technologies
MJ Aardema et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
R Ulrich et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Adverse drug reactions as a cause for admissions to a department of internal medicine
T Mjorndal et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry
DK Han et al.
NATURE BIOTECHNOLOGY (2001)
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles
JF Waring et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
RNA expression in the early characterization of hepatotoxicants in wister rats by high-density DNA microarrays
SJ Bulera et al.
HEPATOLOGY (2001)
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity
JF Waring et al.
TOXICOLOGY LETTERS (2001)
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
MP Washburn et al.
NATURE BIOTECHNOLOGY (2001)
Applications of microarray technology in breast cancer research
CS Cooper
BREAST CANCER RESEARCH (2001)
Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor α or the peroxisome proliferator nafenopin
S Chevalier et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Functional discovery via a compendium of expression profiles
TR Hughes et al.
CELL (2000)
Genomics and proteomics - The new millennium of drug discovery and development
MJ Cunningham
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Genomic analysis
PS Lee et al.
CURRENT OPINION IN BIOTECHNOLOGY (2000)
Share Paper
